List of works - Lisa Detora

A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis.

scientific article published in January 2002

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.

scientific article

Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications ⬇️

scientific article published on June 28, 2011

Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source ⬇️

scientific article published on November 7, 2011

Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease

scientific article

Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults

scientific article published on 01 July 2011

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.

scientific article published on August 2006

Ghostwriting in biomedicine: a review of the published literature

scientific article published on 22 May 2019

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

scientific article published in 2022

Imported Human Rabies Cases in Europe, the United States, and Japan, 1990 to 2010: Table 1 ⬇️

scientific article published on 04 October 2011

Increase of meningococcal serogroup Y cases in Europe: A reason for concern? ⬇️

scientific article published on May 1, 2012

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines

scientific article

Menveo®: a novel quadrivalent meningococcal CRM197conjugate vaccine against serogroups A, C, W-135 and Y ⬇️

scientific article published on January 1, 2011

Peer review in the global digital age: perspectives of publishing industry stakeholders

scientific article published in 2023

Publication ethics from the ground up.

scientific article published on 8 February 2018

Publication planning: promoting an ethics of transparency and integrity in biomedical research

scientific article published on September 2015

Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.

scientific article

Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors

scientific article published on November 1, 2001

Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group

scientific article published on 01 November 2000

Statistical evaluations of the reproducibility and reliability of 3-tesla high resolution magnetization transfer brain images: a pilot study on healthy subjects.

scientific article

Substantial contribution and accountability: best authorship practices for medical writers in biomedical publications.

scientific article published on 16 April 2018

The challenge of post-implementation surveillance for novel meningococcal vaccines.

scientific article published on 09 January 2012

The spectre of ghostwriting: eroding public trust in physicians, clinical trial integrity and biomedical authorship

scientific article published on July 2016

The sunshine act and medical publications: Guidance from professional medical associations.

scientific article published on 27 August 2015

Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway

scientific article published on 12 March 2014

What is safety?: Miracles, benefit-risk assessments, and the "right to try".

scientific article

List of works by Lisa Detora

A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis.

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.

Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications ⬇️

Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source ⬇️

Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease

Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.

Ghostwriting in biomedicine: a review of the published literature

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

Imported Human Rabies Cases in Europe, the United States, and Japan, 1990 to 2010: Table 1 ⬇️

Increase of meningococcal serogroup Y cases in Europe: A reason for concern? ⬇️

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines

Menveo®: a novel quadrivalent meningococcal CRM197conjugate vaccine against serogroups A, C, W-135 and Y ⬇️

Peer review in the global digital age: perspectives of publishing industry stakeholders

Publication ethics from the ground up.

Publication planning: promoting an ethics of transparency and integrity in biomedical research

Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.

Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors

Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group

Statistical evaluations of the reproducibility and reliability of 3-tesla high resolution magnetization transfer brain images: a pilot study on healthy subjects.

Substantial contribution and accountability: best authorship practices for medical writers in biomedical publications.

The challenge of post-implementation surveillance for novel meningococcal vaccines.

The spectre of ghostwriting: eroding public trust in physicians, clinical trial integrity and biomedical authorship

The sunshine act and medical publications: Guidance from professional medical associations.

Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway

What is safety?: Miracles, benefit-risk assessments, and the "right to try".